Correction: Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability
Yuichi Horigome, Koichi Ehata, Noriyuki Tadera, Kei Hayama, Hirotoshi Kamata, Takahiro Suzuki, Koji Miyazaki · 2026
Read Correction: Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability by Yuichi Horigome, Koichi Ehata, Noriyuki Tadera, Kei Hayama, Hirotoshi Kamata, Takahiro Suzuki, Koji Miyazaki (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575054.txt.
Description
n the Materials and Methods section regarding the expansion of the abbreviation “IgRT”. The published text reads: “Image-guided radiation therapy (IgRT) was not routinely administered but was considered at the discretion of the treating physician for patients with severe hypogammaglobulinemia and recurrent infections.
Catalog record
| CREATOR | Yuichi Horigome, Koichi Ehata, Noriyuki Tadera, Kei Hayama, Hirotoshi Kamata, Takahiro Suzuki, Koji Miyazaki |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |